UK-based Horizon Discovery Group has rejected a £270m offer from Abcam, saying that it is highly opportunistic and undervalues the company and its future prospects. Horizon secured an unsolicited and highly conditional proposal from Abcam. […]
Merck has agreed to invest $125m in Moderna Therapeutics under a new agreement that expands the firms’ 2016 partnership to develop messenger RNA (mRNA) cancer vaccines. The deal now includes shared antigen mRNA cancer vaccines […]
Janssen Biotech has agreed to acquire US-based BeneVir Biopharm, a biopharmaceutical company focused on developing oncolytic immunotherapies for cancer, in a deal worth $1.04bn. Janssen Biotech is one of the Janssen Pharmaceutical Companies owned by […]
Agility, a leading global logistics provider, has signed an agreement with Cold Box Express to offer innovative shipping solutions for temperature-sensitive cargo. Cold Box offers an active temperature-control pallet shipper, designed for mixed-load ground transportation. […]
OnKure, the epigenetics-focused drug discovery and development company, has secured $7m series A financing for its research and development activities. Delian Capital led the investment round with participation from existing and new investors including OnKure […]